Sg3 Management, LLC Cara Therapeutics, Inc. Put Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $452,760 - $629,552	-39,200 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $247,600 - $583,800	-20,000 Reduced 33.78%	39,200 $559,000
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $892,144 - $1.29 Million	59,200 New	59,200 $1.29 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15.6M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.